IP Library Granted Patent US 10,947,579
Granted Patent B2
US 10,947,579 · App. 16/053,610 · Granted Mar 16, 2021

Recovering long-range linkage information from preserved samples

Inventors: Christopher John Troll (Santa Cruz, CA); Martin P. Powers (San Francisco, CA); Nicholas H. Putnam (Waltham, MA); Marco Blanchette (Santa Cruz, CA); Paul Hartley (San Jose, CA)
Assignee: DOVETAIL GENOMICS, LLC
C12Q1/6806C12Q1/6816C40B40/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,947,579
App. No.
16/053,610
Granted
Mar 16, 2021
Kind
B2
Abstract

The disclosure provides methods to isolate genome or chromosome level structural information from preserved samples. In some cases, samples preserved under conditions where long-range nucleic acid information is believed to be irreparably lost, such as FFPE samples, are treated to recover nucleic acid-protein complexes stabilized as part of the sample preservation process. The complexes are processed so as to recover information regarding which nucleic acids are bound to a common complex, and the information is used to recover genomic structural information.

Claims (19)

1. A method, comprising

obtaining a preserved sample from a subject, the sample comprising protein-DNA complexes;

treating the preserved sample with a proteinase at a temperature not greater than 40° C. to isolate nucleic acids such that protein-DNA complexes are not destroyed, such that a first double-stranded segment and a second double-stranded segment are held together independent of a phosphodiester backbone, and such that the first double-stranded segment and the second double-stranded segment each have at least one exposed nucleic acid end; and

deriving genomic structural information by analyzing nucleic acids of the protein-DNA complexes in the sample, wherein the preserved sample is a formalin fixed paraffin-embedded (FFPE) sample.

2. The method of claim 1 , wherein the preserved sample is crosslinked.

3. The method of claim 2 , wherein the preserved sample is crosslinked using at least one of a formaldehyde, a formalin, UV light, mitomycin C, nitrogen mustard, melphalan, 1,3-butadiene diepoxide, cis diaminedichloroplatinum(II) and cyclophosphamide.

4. The method of claim 1 , wherein the preserved sample maintains positional information as to nucleic acids within it.

5. The method of claim 1 , wherein the genomic structural information is indicative of a structural variant comprising at least one of an inversion, an insertion, a deletion, a chromosomal translocation, a copy number variant, a loss of heterozygosity, or a gene fusion relative to a reference genome.

6. The method of claim 1 , comprising deriving information indicative of phase status for the first double-stranded segment and the second double-stranded segment of the nucleic acids.

7. The method of claim 1 , comprising tagging an exposed nucleic acid end of the first double-stranded segment and an exposed nucleic acid end of the second double-stranded segment so as to convey physical linkage information.

8. The method of claim 7 , wherein the tagging comprises ligating an oligonucleotide to an exposed end of the first double-stranded segment of the preserved sample such that the oligonucleotide conveys information indicative of genomic structural information.

9. The method of claim 7 , wherein the tagging comprises ligating an exposed end of the first double-stranded segment to an exposed end of the second double-stranded segment to form a paired end molecule.

10. The method of claim 1 , wherein the preserved sample is treated by contacting the preserved tissue sample to at least one of xylene and ethanol.

11. The method of claim 1 , wherein the preserved sample is treated by contacting the preserved tissue sample to at least one of an anthranilate and a phosphanilate.

12. The method of claim 1 , wherein the preserved sample preserves positional information reflective of its configuration in a tissue.

13. The method of claim 1 , wherein the preserved sample is not homogenized prior to isolating nucleic acids.

14. The method of claim 1 , wherein the preserved sample is stored for at least one week prior to isolating nucleic acids.

15. The method of claim 1 , wherein the preserved sample is stored for at least 6 months prior to isolating nucleic acids.

16. The method of claim 1 , wherein the preserved sample is transported from a collection point prior to isolating nucleic acids.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 10, 2019
From: DOVETAIL GENOMICS LLS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 051443/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2018
From: TROLL, CHRISTOPHER JOHN; POWERS, MARTIN P.; PUTNAM, NICHOLAS H.; BLANCHETTE, MARCO; HARTLEY, PAUL
To: DOVETAIL GENOMICS, LLC
Reel/Frame 047033/0105 →
Continuity (4)
Continuation PCTUS2017032466 · May 12, 2017
Provisional Application 62336252 · May 13, 2016
Provisional Application 62410599 · Oct 20, 2016
Related Publication 20190032113A1 · Jan 31, 2019
Cited By (2)
US 12,378,592 US 12,404,537